SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001567619-17-002282
Filing Date
2017-11-01
Accepted
2017-11-01 16:15:52
Documents
4
Period of Report
2017-10-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K s001942x1_8k.htm 8-K 28610
2 EXHIBIT 10.1 s001942x1_ex10-1.htm EX-10.1 82235
3 EXHIBIT 99.1 s001942x1_ex99-1.htm EX-99.1 119665
4 s001942x1ex99-1_image01.jpg GRAPHIC 11403
  Complete submission text file 0001567619-17-002282.txt   242294
Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 171169135
SIC: 2834 Pharmaceutical Preparations